nodes	percent_of_prediction	percent_of_DWPC	metapath
Trametinib—CYP2C8—Trimethadione—epilepsy syndrome	0.0504	0.0923	CbGbCtD
Trametinib—CYP2C8—Fosphenytoin—epilepsy syndrome	0.0474	0.0868	CbGbCtD
Trametinib—CYP2C8—Carbamazepine—epilepsy syndrome	0.0341	0.0623	CbGbCtD
Trametinib—CYP2C8—Primidone—epilepsy syndrome	0.0318	0.0582	CbGbCtD
Trametinib—CYP2C8—Phenytoin—epilepsy syndrome	0.0306	0.0559	CbGbCtD
Trametinib—CYP2C8—Propofol—epilepsy syndrome	0.0285	0.0521	CbGbCtD
Trametinib—CYP2C8—Phenobarbital—epilepsy syndrome	0.0272	0.0498	CbGbCtD
Trametinib—CYP2C8—Diazepam—epilepsy syndrome	0.0258	0.0472	CbGbCtD
Trametinib—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.022	0.0403	CbGbCtD
Trametinib—CYP3A4—Felbamate—epilepsy syndrome	0.0205	0.0374	CbGbCtD
Trametinib—CYP3A4—Trimethadione—epilepsy syndrome	0.0205	0.0374	CbGbCtD
Trametinib—CYP2C8—Valproic Acid—epilepsy syndrome	0.0204	0.0372	CbGbCtD
Trametinib—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0192	0.0352	CbGbCtD
Trametinib—CYP3A4—Clonazepam—epilepsy syndrome	0.0174	0.0318	CbGbCtD
Trametinib—CYP3A4—Clobazam—epilepsy syndrome	0.0167	0.0305	CbGbCtD
Trametinib—CYP3A4—Rufinamide—epilepsy syndrome	0.0142	0.0259	CbGbCtD
Trametinib—CYP3A4—Carbamazepine—epilepsy syndrome	0.0138	0.0253	CbGbCtD
Trametinib—CYP3A4—Primidone—epilepsy syndrome	0.0129	0.0236	CbGbCtD
Trametinib—CYP3A4—Phenytoin—epilepsy syndrome	0.0124	0.0227	CbGbCtD
Trametinib—CYP3A4—Propofol—epilepsy syndrome	0.0116	0.0211	CbGbCtD
Trametinib—CYP3A4—Acetazolamide—epilepsy syndrome	0.011	0.0202	CbGbCtD
Trametinib—CYP3A4—Phenobarbital—epilepsy syndrome	0.011	0.0202	CbGbCtD
Trametinib—CYP3A4—Midazolam—epilepsy syndrome	0.0109	0.0199	CbGbCtD
Trametinib—CYP3A4—Diazepam—epilepsy syndrome	0.0105	0.0192	CbGbCtD
Trametinib—CYP3A4—Zonisamide—epilepsy syndrome	0.0102	0.0187	CbGbCtD
Trametinib—CYP3A4—Valproic Acid—epilepsy syndrome	0.00825	0.0151	CbGbCtD
Trametinib—CYP3A4—Topiramate—epilepsy syndrome	0.00745	0.0136	CbGbCtD
Trametinib—MAP2K1—hindbrain—epilepsy syndrome	0.00486	0.129	CbGeAlD
Trametinib—MAP2K1—brainstem—epilepsy syndrome	0.00279	0.0737	CbGeAlD
Trametinib—MAP2K1—forebrain—epilepsy syndrome	0.00269	0.0712	CbGeAlD
Trametinib—MAP2K1—telencephalon—epilepsy syndrome	0.00247	0.0654	CbGeAlD
Trametinib—MAP2K2—forebrain—epilepsy syndrome	0.00237	0.0627	CbGeAlD
Trametinib—MAP2K2—telencephalon—epilepsy syndrome	0.00218	0.0576	CbGeAlD
Trametinib—MAP2K1—spinal cord—epilepsy syndrome	0.00173	0.0458	CbGeAlD
Trametinib—MAP2K2—medulla oblongata—epilepsy syndrome	0.00171	0.0453	CbGeAlD
Trametinib—MAP2K2—midbrain—epilepsy syndrome	0.00156	0.0414	CbGeAlD
Trametinib—MAP2K1—head—epilepsy syndrome	0.00154	0.0407	CbGeAlD
Trametinib—MAP2K2—spinal cord—epilepsy syndrome	0.00153	0.0404	CbGeAlD
Trametinib—MAP2K1—nervous system—epilepsy syndrome	0.00146	0.0386	CbGeAlD
Trametinib—MAP2K1—central nervous system—epilepsy syndrome	0.00141	0.0372	CbGeAlD
Trametinib—MAP2K1—cerebellum—epilepsy syndrome	0.00137	0.0364	CbGeAlD
Trametinib—MAP2K2—head—epilepsy syndrome	0.00136	0.0359	CbGeAlD
Trametinib—MAP2K2—nervous system—epilepsy syndrome	0.00129	0.034	CbGeAlD
Trametinib—MAP2K2—central nervous system—epilepsy syndrome	0.00124	0.0327	CbGeAlD
Trametinib—MAP2K2—cerebellum—epilepsy syndrome	0.00121	0.032	CbGeAlD
Trametinib—MAP2K1—brain—epilepsy syndrome	0.00112	0.0295	CbGeAlD
Trametinib—MAP2K2—brain—epilepsy syndrome	0.000983	0.026	CbGeAlD
Trametinib—CYP2C8—brain—epilepsy syndrome	0.00034	0.009	CbGeAlD
Trametinib—CYP3A4—nervous system—epilepsy syndrome	0.000302	0.00798	CbGeAlD
Trametinib—CYP3A4—central nervous system—epilepsy syndrome	0.00029	0.00768	CbGeAlD
Trametinib—Asthenia—Felbamate—epilepsy syndrome	0.000103	0.000463	CcSEcCtD
Trametinib—Vision blurred—Pregabalin—epilepsy syndrome	0.000103	0.000463	CcSEcCtD
Trametinib—Arthralgia—Valproic Acid—epilepsy syndrome	0.000103	0.000462	CcSEcCtD
Trametinib—Myalgia—Valproic Acid—epilepsy syndrome	0.000103	0.000462	CcSEcCtD
Trametinib—Haematuria—Topiramate—epilepsy syndrome	0.000103	0.000462	CcSEcCtD
Trametinib—Rash—Midazolam—epilepsy syndrome	0.000102	0.00046	CcSEcCtD
Trametinib—Dizziness—Fosphenytoin—epilepsy syndrome	0.000102	0.000459	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.000102	0.000459	CcSEcCtD
Trametinib—Dermatitis—Midazolam—epilepsy syndrome	0.000102	0.000459	CcSEcCtD
Trametinib—Vomiting—Levetiracetam—epilepsy syndrome	0.000102	0.000458	CcSEcCtD
Trametinib—Epistaxis—Topiramate—epilepsy syndrome	0.000101	0.000457	CcSEcCtD
Trametinib—Headache—Midazolam—epilepsy syndrome	0.000101	0.000457	CcSEcCtD
Trametinib—Pruritus—Felbamate—epilepsy syndrome	0.000101	0.000456	CcSEcCtD
Trametinib—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000101	0.000456	CcSEcCtD
Trametinib—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000101	0.000456	CcSEcCtD
Trametinib—Diarrhoea—Diazepam—epilepsy syndrome	0.000101	0.000456	CcSEcCtD
Trametinib—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000101	0.000456	CcSEcCtD
Trametinib—Rash—Levetiracetam—epilepsy syndrome	0.000101	0.000454	CcSEcCtD
Trametinib—Anaemia—Pregabalin—epilepsy syndrome	0.000101	0.000454	CcSEcCtD
Trametinib—Dermatitis—Levetiracetam—epilepsy syndrome	0.000101	0.000453	CcSEcCtD
Trametinib—Asthenia—Zonisamide—epilepsy syndrome	0.000101	0.000453	CcSEcCtD
Trametinib—Mental disorder—Gabapentin—epilepsy syndrome	0.000101	0.000453	CcSEcCtD
Trametinib—Dry mouth—Valproic Acid—epilepsy syndrome	0.0001	0.000452	CcSEcCtD
Trametinib—Headache—Levetiracetam—epilepsy syndrome	0.0001	0.000451	CcSEcCtD
Trametinib—Malnutrition—Gabapentin—epilepsy syndrome	9.99e-05	0.00045	CcSEcCtD
Trametinib—Erythema—Gabapentin—epilepsy syndrome	9.99e-05	0.00045	CcSEcCtD
Trametinib—Dizziness—Vigabatrin—epilepsy syndrome	9.94e-05	0.000448	CcSEcCtD
Trametinib—Pruritus—Zonisamide—epilepsy syndrome	9.92e-05	0.000447	CcSEcCtD
Trametinib—Oedema—Valproic Acid—epilepsy syndrome	9.84e-05	0.000443	CcSEcCtD
Trametinib—Bradycardia—Topiramate—epilepsy syndrome	9.83e-05	0.000443	CcSEcCtD
Trametinib—Nausea—Propofol—epilepsy syndrome	9.82e-05	0.000442	CcSEcCtD
Trametinib—Vomiting—Fosphenytoin—epilepsy syndrome	9.8e-05	0.000442	CcSEcCtD
Trametinib—Diarrhoea—Felbamate—epilepsy syndrome	9.8e-05	0.000441	CcSEcCtD
Trametinib—Abdominal pain—Lamotrigine—epilepsy syndrome	9.78e-05	0.000441	CcSEcCtD
Trametinib—Body temperature increased—Lamotrigine—epilepsy syndrome	9.78e-05	0.000441	CcSEcCtD
Trametinib—Dysgeusia—Gabapentin—epilepsy syndrome	9.78e-05	0.000441	CcSEcCtD
Trametinib—Dizziness—Diazepam—epilepsy syndrome	9.78e-05	0.000441	CcSEcCtD
Trametinib—Infection—Valproic Acid—epilepsy syndrome	9.77e-05	0.00044	CcSEcCtD
Trametinib—Leukopenia—Pregabalin—epilepsy syndrome	9.75e-05	0.000439	CcSEcCtD
Trametinib—Rash—Fosphenytoin—epilepsy syndrome	9.72e-05	0.000438	CcSEcCtD
Trametinib—Dermatitis—Fosphenytoin—epilepsy syndrome	9.71e-05	0.000438	CcSEcCtD
Trametinib—Haemoglobin—Topiramate—epilepsy syndrome	9.7e-05	0.000437	CcSEcCtD
Trametinib—Asthenia—Clonazepam—epilepsy syndrome	9.69e-05	0.000437	CcSEcCtD
Trametinib—Back pain—Gabapentin—epilepsy syndrome	9.66e-05	0.000435	CcSEcCtD
Trametinib—Headache—Fosphenytoin—epilepsy syndrome	9.66e-05	0.000435	CcSEcCtD
Trametinib—Haemorrhage—Topiramate—epilepsy syndrome	9.66e-05	0.000435	CcSEcCtD
Trametinib—Nervous system disorder—Valproic Acid—epilepsy syndrome	9.65e-05	0.000435	CcSEcCtD
Trametinib—Thrombocytopenia—Valproic Acid—epilepsy syndrome	9.63e-05	0.000434	CcSEcCtD
Trametinib—Asthenia—Phenytoin—epilepsy syndrome	9.63e-05	0.000434	CcSEcCtD
Trametinib—Nausea—Midazolam—epilepsy syndrome	9.61e-05	0.000433	CcSEcCtD
Trametinib—Muscle spasms—Gabapentin—epilepsy syndrome	9.61e-05	0.000433	CcSEcCtD
Trametinib—Diarrhoea—Zonisamide—epilepsy syndrome	9.59e-05	0.000432	CcSEcCtD
Trametinib—Asthenia—Oxcarbazepine—epilepsy syndrome	9.58e-05	0.000431	CcSEcCtD
Trametinib—Pruritus—Clonazepam—epilepsy syndrome	9.56e-05	0.000431	CcSEcCtD
Trametinib—Vomiting—Vigabatrin—epilepsy syndrome	9.55e-05	0.000431	CcSEcCtD
Trametinib—Skin disorder—Valproic Acid—epilepsy syndrome	9.55e-05	0.00043	CcSEcCtD
Trametinib—Urinary tract disorder—Topiramate—epilepsy syndrome	9.54e-05	0.00043	CcSEcCtD
Trametinib—Oedema peripheral—Topiramate—epilepsy syndrome	9.51e-05	0.000429	CcSEcCtD
Trametinib—Hyperhidrosis—Valproic Acid—epilepsy syndrome	9.51e-05	0.000428	CcSEcCtD
Trametinib—Cough—Pregabalin—epilepsy syndrome	9.51e-05	0.000428	CcSEcCtD
Trametinib—Pruritus—Phenytoin—epilepsy syndrome	9.49e-05	0.000428	CcSEcCtD
Trametinib—Connective tissue disorder—Topiramate—epilepsy syndrome	9.49e-05	0.000428	CcSEcCtD
Trametinib—Nausea—Levetiracetam—epilepsy syndrome	9.49e-05	0.000428	CcSEcCtD
Trametinib—Rash—Vigabatrin—epilepsy syndrome	9.47e-05	0.000427	CcSEcCtD
Trametinib—Dizziness—Felbamate—epilepsy syndrome	9.47e-05	0.000427	CcSEcCtD
Trametinib—Dermatitis—Vigabatrin—epilepsy syndrome	9.47e-05	0.000427	CcSEcCtD
Trametinib—Urethral disorder—Topiramate—epilepsy syndrome	9.46e-05	0.000426	CcSEcCtD
Trametinib—Pruritus—Oxcarbazepine—epilepsy syndrome	9.44e-05	0.000425	CcSEcCtD
Trametinib—Vision blurred—Gabapentin—epilepsy syndrome	9.42e-05	0.000424	CcSEcCtD
Trametinib—Headache—Vigabatrin—epilepsy syndrome	9.41e-05	0.000424	CcSEcCtD
Trametinib—Hypertension—Pregabalin—epilepsy syndrome	9.41e-05	0.000424	CcSEcCtD
Trametinib—Vomiting—Diazepam—epilepsy syndrome	9.41e-05	0.000424	CcSEcCtD
Trametinib—Rash—Diazepam—epilepsy syndrome	9.33e-05	0.00042	CcSEcCtD
Trametinib—Dermatitis—Diazepam—epilepsy syndrome	9.32e-05	0.00042	CcSEcCtD
Trametinib—Myalgia—Pregabalin—epilepsy syndrome	9.28e-05	0.000418	CcSEcCtD
Trametinib—Arthralgia—Pregabalin—epilepsy syndrome	9.28e-05	0.000418	CcSEcCtD
Trametinib—Dizziness—Zonisamide—epilepsy syndrome	9.27e-05	0.000418	CcSEcCtD
Trametinib—Headache—Diazepam—epilepsy syndrome	9.27e-05	0.000418	CcSEcCtD
Trametinib—Diarrhoea—Clonazepam—epilepsy syndrome	9.24e-05	0.000416	CcSEcCtD
Trametinib—Anaemia—Gabapentin—epilepsy syndrome	9.23e-05	0.000416	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	9.21e-05	0.000415	CcSEcCtD
Trametinib—Asthenia—Carbamazepine—epilepsy syndrome	9.19e-05	0.000414	CcSEcCtD
Trametinib—Diarrhoea—Phenytoin—epilepsy syndrome	9.18e-05	0.000414	CcSEcCtD
Trametinib—Nausea—Fosphenytoin—epilepsy syndrome	9.16e-05	0.000413	CcSEcCtD
Trametinib—Diarrhoea—Oxcarbazepine—epilepsy syndrome	9.13e-05	0.000411	CcSEcCtD
Trametinib—Vomiting—Felbamate—epilepsy syndrome	9.1e-05	0.00041	CcSEcCtD
Trametinib—Dry mouth—Pregabalin—epilepsy syndrome	9.07e-05	0.000409	CcSEcCtD
Trametinib—Pruritus—Carbamazepine—epilepsy syndrome	9.06e-05	0.000408	CcSEcCtD
Trametinib—Rash—Felbamate—epilepsy syndrome	9.03e-05	0.000407	CcSEcCtD
Trametinib—Eye disorder—Topiramate—epilepsy syndrome	9.02e-05	0.000407	CcSEcCtD
Trametinib—Dermatitis—Felbamate—epilepsy syndrome	9.02e-05	0.000406	CcSEcCtD
Trametinib—Headache—Felbamate—epilepsy syndrome	8.97e-05	0.000404	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	8.96e-05	0.000404	CcSEcCtD
Trametinib—Cardiac disorder—Topiramate—epilepsy syndrome	8.96e-05	0.000404	CcSEcCtD
Trametinib—Leukopenia—Gabapentin—epilepsy syndrome	8.94e-05	0.000403	CcSEcCtD
Trametinib—Dizziness—Clonazepam—epilepsy syndrome	8.93e-05	0.000402	CcSEcCtD
Trametinib—Nausea—Vigabatrin—epilepsy syndrome	8.93e-05	0.000402	CcSEcCtD
Trametinib—Vomiting—Zonisamide—epilepsy syndrome	8.91e-05	0.000402	CcSEcCtD
Trametinib—Insomnia—Valproic Acid—epilepsy syndrome	8.9e-05	0.000401	CcSEcCtD
Trametinib—Oedema—Pregabalin—epilepsy syndrome	8.89e-05	0.000401	CcSEcCtD
Trametinib—Asthenia—Lamotrigine—epilepsy syndrome	8.88e-05	0.0004	CcSEcCtD
Trametinib—Dizziness—Phenytoin—epilepsy syndrome	8.87e-05	0.0004	CcSEcCtD
Trametinib—Rash—Zonisamide—epilepsy syndrome	8.84e-05	0.000398	CcSEcCtD
Trametinib—Infection—Pregabalin—epilepsy syndrome	8.83e-05	0.000398	CcSEcCtD
Trametinib—Dermatitis—Zonisamide—epilepsy syndrome	8.83e-05	0.000398	CcSEcCtD
Trametinib—Dizziness—Oxcarbazepine—epilepsy syndrome	8.83e-05	0.000398	CcSEcCtD
Trametinib—Nausea—Diazepam—epilepsy syndrome	8.79e-05	0.000396	CcSEcCtD
Trametinib—Headache—Zonisamide—epilepsy syndrome	8.78e-05	0.000396	CcSEcCtD
Trametinib—Diarrhoea—Carbamazepine—epilepsy syndrome	8.76e-05	0.000395	CcSEcCtD
Trametinib—Angiopathy—Topiramate—epilepsy syndrome	8.76e-05	0.000395	CcSEcCtD
Trametinib—Pruritus—Lamotrigine—epilepsy syndrome	8.76e-05	0.000395	CcSEcCtD
Trametinib—Nervous system disorder—Pregabalin—epilepsy syndrome	8.72e-05	0.000393	CcSEcCtD
Trametinib—Cough—Gabapentin—epilepsy syndrome	8.72e-05	0.000393	CcSEcCtD
Trametinib—Thrombocytopenia—Pregabalin—epilepsy syndrome	8.71e-05	0.000392	CcSEcCtD
Trametinib—Mediastinal disorder—Topiramate—epilepsy syndrome	8.7e-05	0.000392	CcSEcCtD
Trametinib—Chills—Topiramate—epilepsy syndrome	8.66e-05	0.00039	CcSEcCtD
Trametinib—Skin disorder—Pregabalin—epilepsy syndrome	8.64e-05	0.000389	CcSEcCtD
Trametinib—Hypertension—Gabapentin—epilepsy syndrome	8.63e-05	0.000389	CcSEcCtD
Trametinib—Hyperhidrosis—Pregabalin—epilepsy syndrome	8.6e-05	0.000387	CcSEcCtD
Trametinib—Vomiting—Clonazepam—epilepsy syndrome	8.59e-05	0.000387	CcSEcCtD
Trametinib—Decreased appetite—Valproic Acid—epilepsy syndrome	8.55e-05	0.000385	CcSEcCtD
Trametinib—Vomiting—Phenytoin—epilepsy syndrome	8.53e-05	0.000384	CcSEcCtD
Trametinib—Rash—Clonazepam—epilepsy syndrome	8.52e-05	0.000384	CcSEcCtD
Trametinib—Dermatitis—Clonazepam—epilepsy syndrome	8.51e-05	0.000383	CcSEcCtD
Trametinib—Arthralgia—Gabapentin—epilepsy syndrome	8.51e-05	0.000383	CcSEcCtD
Trametinib—Myalgia—Gabapentin—epilepsy syndrome	8.51e-05	0.000383	CcSEcCtD
Trametinib—Nausea—Felbamate—epilepsy syndrome	8.5e-05	0.000383	CcSEcCtD
Trametinib—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	8.49e-05	0.000383	CcSEcCtD
Trametinib—Vomiting—Oxcarbazepine—epilepsy syndrome	8.49e-05	0.000382	CcSEcCtD
Trametinib—Fatigue—Valproic Acid—epilepsy syndrome	8.48e-05	0.000382	CcSEcCtD
Trametinib—Dizziness—Carbamazepine—epilepsy syndrome	8.47e-05	0.000382	CcSEcCtD
Trametinib—Diarrhoea—Lamotrigine—epilepsy syndrome	8.47e-05	0.000382	CcSEcCtD
Trametinib—Headache—Clonazepam—epilepsy syndrome	8.46e-05	0.000381	CcSEcCtD
Trametinib—Rash—Phenytoin—epilepsy syndrome	8.46e-05	0.000381	CcSEcCtD
Trametinib—Mental disorder—Topiramate—epilepsy syndrome	8.46e-05	0.000381	CcSEcCtD
Trametinib—Dermatitis—Phenytoin—epilepsy syndrome	8.45e-05	0.000381	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	8.45e-05	0.000381	CcSEcCtD
Trametinib—Rash—Oxcarbazepine—epilepsy syndrome	8.41e-05	0.000379	CcSEcCtD
Trametinib—Constipation—Valproic Acid—epilepsy syndrome	8.41e-05	0.000379	CcSEcCtD
Trametinib—Dermatitis—Oxcarbazepine—epilepsy syndrome	8.41e-05	0.000379	CcSEcCtD
Trametinib—Headache—Phenytoin—epilepsy syndrome	8.41e-05	0.000379	CcSEcCtD
Trametinib—Erythema—Topiramate—epilepsy syndrome	8.41e-05	0.000379	CcSEcCtD
Trametinib—Malnutrition—Topiramate—epilepsy syndrome	8.41e-05	0.000379	CcSEcCtD
Trametinib—Headache—Oxcarbazepine—epilepsy syndrome	8.36e-05	0.000377	CcSEcCtD
Trametinib—Nausea—Zonisamide—epilepsy syndrome	8.32e-05	0.000375	CcSEcCtD
Trametinib—Dry mouth—Gabapentin—epilepsy syndrome	8.32e-05	0.000375	CcSEcCtD
Trametinib—Dysgeusia—Topiramate—epilepsy syndrome	8.23e-05	0.000371	CcSEcCtD
Trametinib—Dizziness—Lamotrigine—epilepsy syndrome	8.18e-05	0.000369	CcSEcCtD
Trametinib—Oedema—Gabapentin—epilepsy syndrome	8.15e-05	0.000367	CcSEcCtD
Trametinib—Vomiting—Carbamazepine—epilepsy syndrome	8.14e-05	0.000367	CcSEcCtD
Trametinib—Back pain—Topiramate—epilepsy syndrome	8.13e-05	0.000366	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	8.1e-05	0.000365	CcSEcCtD
Trametinib—Infection—Gabapentin—epilepsy syndrome	8.1e-05	0.000365	CcSEcCtD
Trametinib—Muscle spasms—Topiramate—epilepsy syndrome	8.08e-05	0.000364	CcSEcCtD
Trametinib—Rash—Carbamazepine—epilepsy syndrome	8.08e-05	0.000364	CcSEcCtD
Trametinib—Dermatitis—Carbamazepine—epilepsy syndrome	8.07e-05	0.000364	CcSEcCtD
Trametinib—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	8.04e-05	0.000362	CcSEcCtD
Trametinib—Insomnia—Pregabalin—epilepsy syndrome	8.04e-05	0.000362	CcSEcCtD
Trametinib—Nausea—Clonazepam—epilepsy syndrome	8.02e-05	0.000362	CcSEcCtD
Trametinib—Headache—Carbamazepine—epilepsy syndrome	8.02e-05	0.000362	CcSEcCtD
Trametinib—Nervous system disorder—Gabapentin—epilepsy syndrome	8e-05	0.00036	CcSEcCtD
Trametinib—Thrombocytopenia—Gabapentin—epilepsy syndrome	7.98e-05	0.00036	CcSEcCtD
Trametinib—Nausea—Phenytoin—epilepsy syndrome	7.97e-05	0.000359	CcSEcCtD
Trametinib—Nausea—Oxcarbazepine—epilepsy syndrome	7.93e-05	0.000357	CcSEcCtD
Trametinib—Vision blurred—Topiramate—epilepsy syndrome	7.92e-05	0.000357	CcSEcCtD
Trametinib—Skin disorder—Gabapentin—epilepsy syndrome	7.92e-05	0.000357	CcSEcCtD
Trametinib—Hyperhidrosis—Gabapentin—epilepsy syndrome	7.88e-05	0.000355	CcSEcCtD
Trametinib—Vomiting—Lamotrigine—epilepsy syndrome	7.87e-05	0.000355	CcSEcCtD
Trametinib—Rash—Lamotrigine—epilepsy syndrome	7.8e-05	0.000352	CcSEcCtD
Trametinib—Dermatitis—Lamotrigine—epilepsy syndrome	7.8e-05	0.000351	CcSEcCtD
Trametinib—Body temperature increased—Valproic Acid—epilepsy syndrome	7.78e-05	0.00035	CcSEcCtD
Trametinib—Abdominal pain—Valproic Acid—epilepsy syndrome	7.78e-05	0.00035	CcSEcCtD
Trametinib—Anaemia—Topiramate—epilepsy syndrome	7.77e-05	0.00035	CcSEcCtD
Trametinib—Headache—Lamotrigine—epilepsy syndrome	7.75e-05	0.000349	CcSEcCtD
Trametinib—Decreased appetite—Pregabalin—epilepsy syndrome	7.73e-05	0.000348	CcSEcCtD
Trametinib—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	7.68e-05	0.000346	CcSEcCtD
Trametinib—Fatigue—Pregabalin—epilepsy syndrome	7.67e-05	0.000345	CcSEcCtD
Trametinib—Nausea—Carbamazepine—epilepsy syndrome	7.61e-05	0.000343	CcSEcCtD
Trametinib—Constipation—Pregabalin—epilepsy syndrome	7.6e-05	0.000343	CcSEcCtD
Trametinib—Leukopenia—Topiramate—epilepsy syndrome	7.52e-05	0.000339	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	7.43e-05	0.000335	CcSEcCtD
Trametinib—Insomnia—Gabapentin—epilepsy syndrome	7.37e-05	0.000332	CcSEcCtD
Trametinib—Nausea—Lamotrigine—epilepsy syndrome	7.35e-05	0.000331	CcSEcCtD
Trametinib—Cough—Topiramate—epilepsy syndrome	7.33e-05	0.000331	CcSEcCtD
Trametinib—Gastrointestinal pain—Pregabalin—epilepsy syndrome	7.27e-05	0.000328	CcSEcCtD
Trametinib—Hypertension—Topiramate—epilepsy syndrome	7.26e-05	0.000327	CcSEcCtD
Trametinib—Myalgia—Topiramate—epilepsy syndrome	7.16e-05	0.000322	CcSEcCtD
Trametinib—Arthralgia—Topiramate—epilepsy syndrome	7.16e-05	0.000322	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	7.11e-05	0.00032	CcSEcCtD
Trametinib—Decreased appetite—Gabapentin—epilepsy syndrome	7.09e-05	0.000319	CcSEcCtD
Trametinib—Asthenia—Valproic Acid—epilepsy syndrome	7.06e-05	0.000318	CcSEcCtD
Trametinib—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	7.04e-05	0.000317	CcSEcCtD
Trametinib—Fatigue—Gabapentin—epilepsy syndrome	7.03e-05	0.000317	CcSEcCtD
Trametinib—Body temperature increased—Pregabalin—epilepsy syndrome	7.03e-05	0.000317	CcSEcCtD
Trametinib—Abdominal pain—Pregabalin—epilepsy syndrome	7.03e-05	0.000317	CcSEcCtD
Trametinib—Dry mouth—Topiramate—epilepsy syndrome	7e-05	0.000315	CcSEcCtD
Trametinib—Constipation—Gabapentin—epilepsy syndrome	6.97e-05	0.000314	CcSEcCtD
Trametinib—Pruritus—Valproic Acid—epilepsy syndrome	6.96e-05	0.000314	CcSEcCtD
Trametinib—Oedema—Topiramate—epilepsy syndrome	6.86e-05	0.000309	CcSEcCtD
Trametinib—Infection—Topiramate—epilepsy syndrome	6.81e-05	0.000307	CcSEcCtD
Trametinib—Diarrhoea—Valproic Acid—epilepsy syndrome	6.73e-05	0.000303	CcSEcCtD
Trametinib—Nervous system disorder—Topiramate—epilepsy syndrome	6.73e-05	0.000303	CcSEcCtD
Trametinib—Thrombocytopenia—Topiramate—epilepsy syndrome	6.72e-05	0.000303	CcSEcCtD
Trametinib—Gastrointestinal pain—Gabapentin—epilepsy syndrome	6.67e-05	0.0003	CcSEcCtD
Trametinib—Skin disorder—Topiramate—epilepsy syndrome	6.66e-05	0.0003	CcSEcCtD
Trametinib—Hyperhidrosis—Topiramate—epilepsy syndrome	6.63e-05	0.000299	CcSEcCtD
Trametinib—Dizziness—Valproic Acid—epilepsy syndrome	6.5e-05	0.000293	CcSEcCtD
Trametinib—Abdominal pain—Gabapentin—epilepsy syndrome	6.45e-05	0.00029	CcSEcCtD
Trametinib—Body temperature increased—Gabapentin—epilepsy syndrome	6.45e-05	0.00029	CcSEcCtD
Trametinib—Asthenia—Pregabalin—epilepsy syndrome	6.38e-05	0.000287	CcSEcCtD
Trametinib—Pruritus—Pregabalin—epilepsy syndrome	6.29e-05	0.000283	CcSEcCtD
Trametinib—Vomiting—Valproic Acid—epilepsy syndrome	6.25e-05	0.000282	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	6.25e-05	0.000282	CcSEcCtD
Trametinib—Insomnia—Topiramate—epilepsy syndrome	6.2e-05	0.00028	CcSEcCtD
Trametinib—Rash—Valproic Acid—epilepsy syndrome	6.2e-05	0.000279	CcSEcCtD
Trametinib—Dermatitis—Valproic Acid—epilepsy syndrome	6.2e-05	0.000279	CcSEcCtD
Trametinib—Headache—Valproic Acid—epilepsy syndrome	6.16e-05	0.000278	CcSEcCtD
Trametinib—Diarrhoea—Pregabalin—epilepsy syndrome	6.08e-05	0.000274	CcSEcCtD
Trametinib—Decreased appetite—Topiramate—epilepsy syndrome	5.96e-05	0.000269	CcSEcCtD
Trametinib—Gastrointestinal disorder—Topiramate—epilepsy syndrome	5.92e-05	0.000267	CcSEcCtD
Trametinib—Fatigue—Topiramate—epilepsy syndrome	5.91e-05	0.000266	CcSEcCtD
Trametinib—Dizziness—Pregabalin—epilepsy syndrome	5.88e-05	0.000265	CcSEcCtD
Trametinib—Constipation—Topiramate—epilepsy syndrome	5.87e-05	0.000264	CcSEcCtD
Trametinib—Asthenia—Gabapentin—epilepsy syndrome	5.85e-05	0.000264	CcSEcCtD
Trametinib—Nausea—Valproic Acid—epilepsy syndrome	5.84e-05	0.000263	CcSEcCtD
Trametinib—Pruritus—Gabapentin—epilepsy syndrome	5.77e-05	0.00026	CcSEcCtD
Trametinib—Vomiting—Pregabalin—epilepsy syndrome	5.65e-05	0.000255	CcSEcCtD
Trametinib—Gastrointestinal pain—Topiramate—epilepsy syndrome	5.61e-05	0.000253	CcSEcCtD
Trametinib—Rash—Pregabalin—epilepsy syndrome	5.61e-05	0.000253	CcSEcCtD
Trametinib—Dermatitis—Pregabalin—epilepsy syndrome	5.6e-05	0.000252	CcSEcCtD
Trametinib—Diarrhoea—Gabapentin—epilepsy syndrome	5.58e-05	0.000251	CcSEcCtD
Trametinib—Headache—Pregabalin—epilepsy syndrome	5.57e-05	0.000251	CcSEcCtD
Trametinib—Abdominal pain—Topiramate—epilepsy syndrome	5.42e-05	0.000244	CcSEcCtD
Trametinib—Body temperature increased—Topiramate—epilepsy syndrome	5.42e-05	0.000244	CcSEcCtD
Trametinib—Dizziness—Gabapentin—epilepsy syndrome	5.39e-05	0.000243	CcSEcCtD
Trametinib—Nausea—Pregabalin—epilepsy syndrome	5.28e-05	0.000238	CcSEcCtD
Trametinib—Vomiting—Gabapentin—epilepsy syndrome	5.18e-05	0.000234	CcSEcCtD
Trametinib—Rash—Gabapentin—epilepsy syndrome	5.14e-05	0.000232	CcSEcCtD
Trametinib—Dermatitis—Gabapentin—epilepsy syndrome	5.14e-05	0.000231	CcSEcCtD
Trametinib—Headache—Gabapentin—epilepsy syndrome	5.11e-05	0.00023	CcSEcCtD
Trametinib—Asthenia—Topiramate—epilepsy syndrome	4.92e-05	0.000222	CcSEcCtD
Trametinib—Pruritus—Topiramate—epilepsy syndrome	4.85e-05	0.000219	CcSEcCtD
Trametinib—Nausea—Gabapentin—epilepsy syndrome	4.84e-05	0.000218	CcSEcCtD
Trametinib—Diarrhoea—Topiramate—epilepsy syndrome	4.69e-05	0.000211	CcSEcCtD
Trametinib—Dizziness—Topiramate—epilepsy syndrome	4.54e-05	0.000204	CcSEcCtD
Trametinib—Vomiting—Topiramate—epilepsy syndrome	4.36e-05	0.000197	CcSEcCtD
Trametinib—Rash—Topiramate—epilepsy syndrome	4.33e-05	0.000195	CcSEcCtD
Trametinib—Dermatitis—Topiramate—epilepsy syndrome	4.32e-05	0.000195	CcSEcCtD
Trametinib—Headache—Topiramate—epilepsy syndrome	4.3e-05	0.000194	CcSEcCtD
Trametinib—Nausea—Topiramate—epilepsy syndrome	4.07e-05	0.000184	CcSEcCtD
Trametinib—MAP2K2—Signaling Pathways—DUSP6—epilepsy syndrome	9.59e-06	4.95e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CACNA1D—epilepsy syndrome	9.57e-06	4.94e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—ADRA2A—epilepsy syndrome	9.47e-06	4.89e-05	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—SRC—epilepsy syndrome	9.45e-06	4.88e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PLAT—epilepsy syndrome	9.43e-06	4.87e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—YWHAZ—epilepsy syndrome	9.38e-06	4.84e-05	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—JUN—epilepsy syndrome	9.31e-06	4.8e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PTK2B—epilepsy syndrome	9.31e-06	4.8e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TSC1—epilepsy syndrome	9.31e-06	4.8e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GAMT—epilepsy syndrome	9.29e-06	4.8e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	9.29e-06	4.8e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	9.29e-06	4.8e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PNPO—epilepsy syndrome	9.29e-06	4.8e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—HES1—epilepsy syndrome	9.26e-06	4.78e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—YWHAZ—epilepsy syndrome	9.26e-06	4.78e-05	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—VEGFA—epilepsy syndrome	9.21e-06	4.75e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—AGT—epilepsy syndrome	9.17e-06	4.73e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—BDKRB2—epilepsy syndrome	9.1e-06	4.7e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CXCL12—epilepsy syndrome	9.1e-06	4.7e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—AKT1—epilepsy syndrome	9.09e-06	4.7e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—PRKCB—epilepsy syndrome	9.05e-06	4.67e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—SST—epilepsy syndrome	9.05e-06	4.67e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NTRK2—epilepsy syndrome	9.05e-06	4.67e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCR2—epilepsy syndrome	9.05e-06	4.67e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—IL6ST—epilepsy syndrome	9.02e-06	4.66e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—FYN—epilepsy syndrome	9.01e-06	4.65e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—H2AFX—epilepsy syndrome	8.98e-06	4.63e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—DUSP6—epilepsy syndrome	8.97e-06	4.63e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—TSC2—epilepsy syndrome	8.96e-06	4.63e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CRP—epilepsy syndrome	8.96e-06	4.63e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—TXNRD1—epilepsy syndrome	8.95e-06	4.62e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—JUNB—epilepsy syndrome	8.93e-06	4.61e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CNR1—epilepsy syndrome	8.93e-06	4.61e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CCR5—epilepsy syndrome	8.9e-06	4.6e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PLCB1—epilepsy syndrome	8.9e-06	4.59e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—ADRA2A—epilepsy syndrome	8.86e-06	4.57e-05	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—SRC—epilepsy syndrome	8.84e-06	4.57e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PLAT—epilepsy syndrome	8.82e-06	4.55e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HTR7—epilepsy syndrome	8.71e-06	4.5e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—JUN—epilepsy syndrome	8.71e-06	4.49e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—AQP1—epilepsy syndrome	8.69e-06	4.49e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—YWHAZ—epilepsy syndrome	8.66e-06	4.47e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CA4—epilepsy syndrome	8.64e-06	4.46e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—QDPR—epilepsy syndrome	8.64e-06	4.46e-05	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—VEGFA—epilepsy syndrome	8.61e-06	4.45e-05	CbGpPWpGaD
Trametinib—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	8.61e-06	4.45e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CXCL12—epilepsy syndrome	8.51e-06	4.39e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—BDKRB2—epilepsy syndrome	8.51e-06	4.39e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—AKT1—epilepsy syndrome	8.51e-06	4.39e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—PRKCB—epilepsy syndrome	8.47e-06	4.37e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HBEGF—epilepsy syndrome	8.46e-06	4.37e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—IL6ST—epilepsy syndrome	8.44e-06	4.36e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—TSC2—epilepsy syndrome	8.39e-06	4.33e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CRP—epilepsy syndrome	8.39e-06	4.33e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—JUNB—epilepsy syndrome	8.35e-06	4.31e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CNR1—epilepsy syndrome	8.35e-06	4.31e-05	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—SRC—epilepsy syndrome	8.35e-06	4.31e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	8.35e-06	4.31e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CCR5—epilepsy syndrome	8.33e-06	4.3e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PLCB1—epilepsy syndrome	8.32e-06	4.3e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—AKT3—epilepsy syndrome	8.3e-06	4.29e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—TSC2—epilepsy syndrome	8.28e-06	4.27e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—PRKCB—epilepsy syndrome	8.27e-06	4.27e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—POMC—epilepsy syndrome	8.25e-06	4.26e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL6ST—epilepsy syndrome	8.24e-06	4.25e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HTR7—epilepsy syndrome	8.15e-06	4.21e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—COX3—epilepsy syndrome	8.12e-06	4.19e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—ADAM10—epilepsy syndrome	8.11e-06	4.19e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—APOE—epilepsy syndrome	8.1e-06	4.18e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—CCL2—epilepsy syndrome	8.07e-06	4.17e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HBEGF—epilepsy syndrome	7.91e-06	4.08e-05	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—TNF—epilepsy syndrome	7.89e-06	4.07e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CHRM3—epilepsy syndrome	7.86e-06	4.06e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—KCNJ11—epilepsy syndrome	7.86e-06	4.06e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—SRC—epilepsy syndrome	7.81e-06	4.03e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—AKT3—epilepsy syndrome	7.77e-06	4.01e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—TSC2—epilepsy syndrome	7.74e-06	4e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—PRKCB—epilepsy syndrome	7.74e-06	4e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—POMC—epilepsy syndrome	7.72e-06	3.98e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL6ST—epilepsy syndrome	7.71e-06	3.98e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	7.7e-06	3.97e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PFKL—epilepsy syndrome	7.7e-06	3.97e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	7.7e-06	3.97e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	7.7e-06	3.97e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	7.7e-06	3.97e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—S100B—epilepsy syndrome	7.67e-06	3.96e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—IL6ST—epilepsy syndrome	7.61e-06	3.93e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—SOCS3—epilepsy syndrome	7.59e-06	3.92e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—ADAM10—epilepsy syndrome	7.59e-06	3.92e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—APOE—epilepsy syndrome	7.58e-06	3.91e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CDC42—epilepsy syndrome	7.57e-06	3.91e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—CCL2—epilepsy syndrome	7.55e-06	3.9e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—FOS—epilepsy syndrome	7.55e-06	3.9e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—NOS2—epilepsy syndrome	7.55e-06	3.9e-05	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—TNF—epilepsy syndrome	7.38e-06	3.81e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CASP8—epilepsy syndrome	7.37e-06	3.81e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—AVP—epilepsy syndrome	7.33e-06	3.79e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	7.32e-06	3.78e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—S100B—epilepsy syndrome	7.17e-06	3.7e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	7.17e-06	3.7e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—IL6ST—epilepsy syndrome	7.12e-06	3.67e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—SOCS3—epilepsy syndrome	7.1e-06	3.67e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CDC42—epilepsy syndrome	7.09e-06	3.66e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—FOS—epilepsy syndrome	7.06e-06	3.65e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—NOS2—epilepsy syndrome	7.06e-06	3.65e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—UPB1—epilepsy syndrome	7.04e-06	3.64e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ATIC—epilepsy syndrome	7.04e-06	3.64e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—NEU1—epilepsy syndrome	7.04e-06	3.64e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HES1—epilepsy syndrome	6.93e-06	3.58e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CASP8—epilepsy syndrome	6.9e-06	3.56e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—AVP—epilepsy syndrome	6.86e-06	3.54e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	6.78e-06	3.5e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—FYN—epilepsy syndrome	6.74e-06	3.48e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—H2AFX—epilepsy syndrome	6.72e-06	3.47e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MEF2C—epilepsy syndrome	6.71e-06	3.46e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—FGF2—epilepsy syndrome	6.66e-06	3.44e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	6.55e-06	3.38e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GBE1—epilepsy syndrome	6.55e-06	3.38e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HES1—epilepsy syndrome	6.49e-06	3.35e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—YWHAZ—epilepsy syndrome	6.48e-06	3.35e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NGF—epilepsy syndrome	6.41e-06	3.31e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	6.41e-06	3.31e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—BCL2—epilepsy syndrome	6.33e-06	3.27e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—FYN—epilepsy syndrome	6.31e-06	3.26e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—H2AFX—epilepsy syndrome	6.29e-06	3.24e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MEF2C—epilepsy syndrome	6.27e-06	3.24e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	6.24e-06	3.22e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—FGF2—epilepsy syndrome	6.24e-06	3.22e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCR5—epilepsy syndrome	6.23e-06	3.22e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	6.2e-06	3.2e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—RELA—epilepsy syndrome	6.19e-06	3.19e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	6.16e-06	3.18e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	6.15e-06	3.18e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—FGF2—epilepsy syndrome	6.15e-06	3.18e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HTR2A—epilepsy syndrome	6.1e-06	3.15e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—MTOR—epilepsy syndrome	6.07e-06	3.13e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—YWHAZ—epilepsy syndrome	6.06e-06	3.13e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NGF—epilepsy syndrome	6e-06	3.1e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	5.99e-06	3.09e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—BCL2—epilepsy syndrome	5.92e-06	3.06e-05	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—AKT1—epilepsy syndrome	5.87e-06	3.03e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—NT5E—epilepsy syndrome	5.83e-06	3.01e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ALAD—epilepsy syndrome	5.83e-06	3.01e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCR5—epilepsy syndrome	5.83e-06	3.01e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TSC2—epilepsy syndrome	5.8e-06	2.99e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—AGT—epilepsy syndrome	5.79e-06	2.99e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—RELA—epilepsy syndrome	5.79e-06	2.99e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—FGF2—epilepsy syndrome	5.76e-06	2.97e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HTR2A—epilepsy syndrome	5.71e-06	2.95e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—MTOR—epilepsy syndrome	5.68e-06	2.93e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—APOE—epilepsy syndrome	5.67e-06	2.93e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.62e-06	2.9e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—MTOR—epilepsy syndrome	5.6e-06	2.89e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	5.6e-06	2.89e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL1B—epilepsy syndrome	5.59e-06	2.89e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	5.57e-06	2.87e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	5.57e-06	2.87e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—KDR—epilepsy syndrome	5.56e-06	2.87e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PTGS2—epilepsy syndrome	5.55e-06	2.87e-05	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—AKT1—epilepsy syndrome	5.5e-06	2.84e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	5.45e-06	2.81e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TSC2—epilepsy syndrome	5.42e-06	2.8e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—JUN—epilepsy syndrome	5.42e-06	2.8e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—AGT—epilepsy syndrome	5.42e-06	2.8e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PRKCB—epilepsy syndrome	5.35e-06	2.76e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ADSL—epilepsy syndrome	5.34e-06	2.76e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	5.33e-06	2.75e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IL6ST—epilepsy syndrome	5.33e-06	2.75e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—BCHE—epilepsy syndrome	5.31e-06	2.74e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—APOE—epilepsy syndrome	5.31e-06	2.74e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—MTOR—epilepsy syndrome	5.24e-06	2.71e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GLUL—epilepsy syndrome	5.23e-06	2.7e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL1B—epilepsy syndrome	5.23e-06	2.7e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—KDR—epilepsy syndrome	5.2e-06	2.68e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PTGS2—epilepsy syndrome	5.19e-06	2.68e-05	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—AKT1—epilepsy syndrome	5.19e-06	2.68e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	5.14e-06	2.65e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—JUN—epilepsy syndrome	5.07e-06	2.62e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	5.06e-06	2.61e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	5.01e-06	2.59e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PRKCB—epilepsy syndrome	5e-06	2.58e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—TH—epilepsy syndrome	4.99e-06	2.58e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL6ST—epilepsy syndrome	4.98e-06	2.57e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.91e-06	2.54e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—POMC—epilepsy syndrome	4.87e-06	2.52e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—SRC—epilepsy syndrome	4.86e-06	2.51e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—AKT1—epilepsy syndrome	4.85e-06	2.51e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	4.8e-06	2.48e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCL2—epilepsy syndrome	4.77e-06	2.46e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—AQP1—epilepsy syndrome	4.66e-06	2.41e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—POMC—epilepsy syndrome	4.56e-06	2.35e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—SRC—epilepsy syndrome	4.55e-06	2.35e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—SRC—epilepsy syndrome	4.49e-06	2.32e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCL2—epilepsy syndrome	4.46e-06	2.3e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—FGF2—epilepsy syndrome	4.31e-06	2.22e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	4.22e-06	2.18e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	4.22e-06	2.18e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—SRC—epilepsy syndrome	4.2e-06	2.17e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	4.17e-06	2.15e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CAT—epilepsy syndrome	4.11e-06	2.12e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—FGF2—epilepsy syndrome	4.03e-06	2.08e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—RELA—epilepsy syndrome	4e-06	2.06e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	4e-06	2.06e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MTOR—epilepsy syndrome	3.92e-06	2.02e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—RELA—epilepsy syndrome	3.74e-06	1.93e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GPX1—epilepsy syndrome	3.72e-06	1.92e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MTOR—epilepsy syndrome	3.67e-06	1.89e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CASP3—epilepsy syndrome	3.61e-06	1.86e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—JUN—epilepsy syndrome	3.5e-06	1.81e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	3.44e-06	1.78e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MMP9—epilepsy syndrome	3.41e-06	1.76e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CASP3—epilepsy syndrome	3.38e-06	1.74e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	3.35e-06	1.73e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	3.33e-06	1.72e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—AKT1—epilepsy syndrome	3.31e-06	1.71e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—JUN—epilepsy syndrome	3.28e-06	1.69e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—AGT—epilepsy syndrome	3.26e-06	1.68e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—APOE—epilepsy syndrome	3.19e-06	1.65e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MMP9—epilepsy syndrome	3.19e-06	1.65e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—SRC—epilepsy syndrome	3.14e-06	1.62e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—AKT1—epilepsy syndrome	3.09e-06	1.6e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—VEGFA—epilepsy syndrome	3.06e-06	1.58e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—AKT1—epilepsy syndrome	3.02e-06	1.56e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	3.01e-06	1.55e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—SRC—epilepsy syndrome	2.94e-06	1.52e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—VEGFA—epilepsy syndrome	2.86e-06	1.48e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.86e-06	1.48e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.85e-06	1.47e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—AKT1—epilepsy syndrome	2.83e-06	1.46e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—AKT1—epilepsy syndrome	2.79e-06	1.44e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—POMC—epilepsy syndrome	2.74e-06	1.42e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.72e-06	1.4e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.69e-06	1.39e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—TH—epilepsy syndrome	2.68e-06	1.38e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—AKT1—epilepsy syndrome	2.61e-06	1.35e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ALB—epilepsy syndrome	2.5e-06	1.29e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2.24e-06	1.15e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.21e-06	1.14e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	2.19e-06	1.13e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.15e-06	1.11e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GPX1—epilepsy syndrome	2e-06	1.03e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—AKT1—epilepsy syndrome	1.95e-06	1.01e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—AKT1—epilepsy syndrome	1.83e-06	9.43e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.75e-06	9.03e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.71e-06	8.85e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.47e-06	7.6e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.34e-06	6.93e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.17e-06	6.06e-06	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—AKT1—epilepsy syndrome	1.1e-06	5.68e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—AKT1—epilepsy syndrome	5.9e-07	3.05e-06	CbGpPWpGaD
